ARWR vs GPN · rev $829.4M vs P/E 24, rev $6.29B
Arrowhead Pharmaceuticals Inc (ARWR) versus Global Payments Inc (GPN) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
ARWR currently screens at market cap $10.59B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Not investment advice. Open the ARWR and GPN stock pages for the full models.
Not investment advice.